Literature DB >> 8970217

Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus.

K McIntosh1, A Shevitz, D Zaknun, J Kornegay, P Chatis, N Karthas, S K Burchett.   

Abstract

BACKGROUND: It is known that plasma or serum viral load is high in vertically HIV-infected children during the first year of life, but the changes in these titers after the first birthday have not been described. Information on the natural history of circulating extracellular virus will be useful in elucidating the pathogenesis of pediatric HIV infection and in using viral load measurement to guide prognosis and therapy.
METHODS: We measured serum RNA by reverse transcriptase-polymerase chain reaction and immune complex-dissociated p24 antigen enzyme-linked immunosorbent assay over time in 48 unselected children followed in our clinics and analyzed the findings in relation to age and clinical outcome.
RESULTS: In first-available samples from the 48 children there was a gradual reduction in HIV RNA values with increasing age, with a slope of -0.21 log copy/ml/year (P < 0.001, R2 = 0.6022). This downward trend was seen in subsets of children with all degrees of immunodeficiency. The mean slope of repeated HIV RNA measurements in individual children was similarly in a downward direction (slope -0.11 (P = 0.007 for difference from zero)). The slope was more negative in children who were younger at baseline. Immune complex-dissociated p24 antigen values were much less predictable and predictive.
CONCLUSIONS: Viral load in vertically infected children, measured by reverse transcriptase-polymerase chain reaction, falls very gradually over time, descending from very high titers at the end of the first year, and reaching values seen in horizontally infected adults at approximately 5 years of age.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8970217     DOI: 10.1097/00006454-199612000-00006

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  27 in total

1.  Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.

Authors:  P J Goulder; C Brander; K Annamalai; N Mngqundaniso; U Govender; Y Tang; S He; K E Hartman; C A O'Callaghan; G S Ogg; M A Altfeld; E S Rosenberg; H Cao; S A Kalams; M Hammond; M Bunce; S I Pelton; S A Burchett; K McIntosh; H M Coovadia; B D Walker
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Identification of human endogenous retrovirus-specific T cell responses in vertically HIV-1-infected subjects.

Authors:  Ravi Tandon; Devi SenGupta; Lishomwa C Ndhlovu; Raphaella G S Vieira; R Brad Jones; Vanessa A York; Vinicius A Vieira; Elizabeth R Sharp; Andrew A Wiznia; Mario A Ostrowski; Michael G Rosenberg; Douglas F Nixon
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

3.  Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.

Authors:  Stephanie Shiau; Renate Strehlau; Karl-Günter Technau; Faeezah Patel; Stephen M Arpadi; Ashraf Coovadia; Elaine J Abrams; Louise Kuhn
Journal:  AIDS       Date:  2017-01-28       Impact factor: 4.177

4.  12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort study.

Authors:  Karl-Günter Technau; Renate Strehlau; Faeezah Patel; Stephanie Shiau; Megan Burke; Martie Conradie; Gillian Sorour; Gayle G Sherman; Ashraf Coovadia; Pamela M Murnane; Elaine J Abrams; Louise Kuhn
Journal:  Lancet HIV       Date:  2018-11-08       Impact factor: 12.767

Review 5.  The HIV-1 antibody response: a footprint of the viral reservoir in children vertically infected with HIV.

Authors:  Paolo Palma; Margaret McManus; Nicola Cotugno; Salvatore Rocca; Paolo Rossi; Katherine Luzuriaga
Journal:  Lancet HIV       Date:  2020-05       Impact factor: 12.767

Review 6.  The role of protease inhibitor therapy in children with HIV infection.

Authors:  Patrick J Gavin; Ram Yogev
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

7.  Maternal transmission of human immunodeficiency virus escape mutations subverts HLA-B57 immunodominance but facilitates viral control in the haploidentical infant.

Authors:  Arne Schneidewind; Yanhua Tang; Mark A Brockman; Elizabeth G Ryland; Jacqueline Dunkley-Thompson; Julianne C Steel-Duncan; M Anne St John; Joseph A Conrad; Spyros A Kalams; Francine Noel; Todd M Allen; Celia D Christie; Margaret E Feeney
Journal:  J Virol       Date:  2009-06-10       Impact factor: 5.103

8.  Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants.

Authors:  K Luzuriaga; H Wu; M McManus; P Britto; W Borkowsky; S Burchett; B Smith; L Mofenson; J L Sullivan
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

Review 9.  Immunology of pediatric HIV infection.

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting.

Authors:  Kunjal Patel; Miguel A Hernán; Paige L Williams; John D Seeger; Kenneth McIntosh; Russell B Van Dyke; George R Seage
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.